The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 24, 2017

Filed:

Jul. 13, 2012
Applicants:

Anders H. Berg, Dedham, MA (US);

S. Ananth Karumanchi, Chestnut Hill, MA (US);

Ravi I. Thadhani, Boston, MA (US);

Inventors:

Anders H. Berg, Dedham, MA (US);

S. Ananth Karumanchi, Chestnut Hill, MA (US);

Ravi I. Thadhani, Boston, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 38/06 (2006.01); A61K 38/05 (2006.01); A61K 45/06 (2006.01); G01N 33/68 (2006.01); C07K 16/20 (2006.01); A61K 31/145 (2006.01); A61K 31/255 (2006.01); A61K 31/4172 (2006.01);
U.S. Cl.
CPC ...
A61K 38/063 (2013.01); A61K 31/145 (2013.01); A61K 31/198 (2013.01); A61K 31/255 (2013.01); A61K 31/4172 (2013.01); A61K 38/05 (2013.01); A61K 38/06 (2013.01); A61K 45/06 (2013.01); C07K 16/205 (2013.01); G01N 33/6806 (2013.01); G01N 33/6893 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); G01N 2333/765 (2013.01); G01N 2440/00 (2013.01); G01N 2800/347 (2013.01);
Abstract

The present invention relates to the discovery that an increased fraction of albumin is carbamylated in patients suffering from kidney disease (e.g., end-stage renal disease) and that the fraction of carbamylated albumin is also correlated with increased disease severity, particularly risk of mortality. The present invention also relates to the discovery that free amino acids can reduce carbamylation of albumin. Based on these discoveries the present invention provides diagnostic and prognostic methods for patients suffering from, or suspected of suffering from kidney disease. The invention also provides methods for treating kidney disease by administration of a compound or composition that reduced protein carbamylation, such as free amino acids or dipeptides.


Find Patent Forward Citations

Loading…